International Flavors & Fragrances reported second-quarter 2026 results with revenue of $1.95B, up from $1.92B a year earlier, while net income fell to $50M and diluted EPS declined to $0.2— as disclosed in the company's 10-Q filing.
Financial Highlights
| MetricCurrent quarterPrior year quarterYoY change | Revenue¹$1.95B$1.92B1.8% | Net income²$50M$599M(91.7%) | Diluted EPS³$0.2$2.33(91.4%) |
¹ Reported as “Net sales”. ² Reported as “Net income (loss) attributable to IFF shareholders”. ³ Reported as “Net income (loss) per share - diluted”.
Business Highlights
- Revenue growth in the quarter was driven by Taste, Health & Biosciences and Scent, with volume and pricing gains across Flavors, Fragrance Compounds and Health & Biosciences improving segment performance and gross margins.
- Company completed multiple divestitures including Pharma Solutions, Nitrocellulose and Rene Laurent; Food Ingredients has been classified as held for sale, affecting comparability.
- Operational efficiency, tariff refunds and lower restructuring costs boosted gross profit and adjusted EBITDA margins; productivity gains remain a focus.
- Capital allocation adjusted with capex around 6% of sales, cash repatriation planning underway, and an enhanced share repurchase authorization tied to the divestiture timeline.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.